The FDA announced that it will gradually remove animal testing from the drug development process in a period of 3-5 years. This decision will negatively affect Charles River's revenues. The DCF model ...
T. Rowe Price Transitions to Charles River’s Enterprise Multi-Asset Investment Management Platform
Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles River Investment Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback